US Broker Ratings

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 198% Upside Potential in Biotechnology

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a San Francisco-based biotechnology company, is capturing investor attention with its innovative approach to drug discovery and development. As a clinical-stage..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Look at Growth Amidst Financial Challenges

Sonida Senior Living, Inc. (NASDAQ: SNDA), a key player in the healthcare sector, operates senior housing communities across the United States. With a market capitalization of..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Firm with a 45% Upside Potential

Investors interested in the biotechnology sector should pay close attention to Immunome, Inc. (NASDAQ: IMNM), a clinical-stage company focused on innovative cancer therapies. With a current..

AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest

AngioDynamics, Inc. (NASDAQ: ANGO) is making waves in the healthcare sector with its innovative medical technology solutions. Despite a challenging financial landscape, the company presents a..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating Biotech’s Volatile Waters with a Precise Focus on Cancer Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making strides in the healthcare sector with its innovative approach to oncolytic immunotherapies aimed at treating..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring the 197.98% Upside Potential

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its compelling growth potential and innovative approach in the biotechnology sector. Headquartered in Watertown,..

Akso Health Group (AHG) Stock Analysis: Navigating a 415.8% Revenue Growth in China’s Medical Distribution Sector

Akso Health Group (NASDAQ: AHG) is making waves in the healthcare sector, particularly within the medical distribution industry in China. With a market capitalization of $911.67..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 62.73% Upside in the Biotech Arena

Oruka Therapeutics, Inc. (ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is making waves in the biotechnology sector by focusing on innovative monoclonal antibody..

Humacyte, Inc. (HUMA): Analyst Ratings Highlight a 387% Potential Upside for Innovative Biotech Pioneer

Humacyte, Inc. (NASDAQ: HUMA) stands out in the biotechnology sector with its cutting-edge approach to developing off-the-shelf, implantable bioengineered human tissues. As the healthcare landscape continues..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a Challenging Landscape with -11.70% Revenue Growth

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, presents a unique case study for investors considering the intersection of innovation and..

Opthea Limited (OPT) Stock Analysis: Navigating the -70.67% Downside Amid Biotech Ambitions

Opthea Limited (NASDAQ: OPT), an Australian biotechnology firm, is at the forefront of developing cutting-edge therapies for ocular conditions. With its core research concentrated on vascular..

Standard BioTools Inc. (LAB) Stock Analysis: Is a 37.6% Upside Within Reach for This Healthcare Innovator?

Standard BioTools Inc. (NASDAQ: LAB), a dynamic player in the medical devices industry, has piqued investor interest with a potential upside of 37.6%, according to recent..

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a 472.75% Potential Upside in T Cell Therapy Innovation

Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering player in the biotechnology sector, is capturing investor attention with its innovative T cell therapies aimed at treating cancer..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Exploring a Potential Upside of 153.42%

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company nestled in the healthcare sector, is gaining traction among investors intrigued by its promising potential upside. With a..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Surmodics, Inc. (SRDX) Stock Analysis: Evaluating Its Position Amid Healthcare Challenges

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, specifically within the medical devices industry, presents a fascinating case for investors as it navigates..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A 59.82% Upside Potential Sparks Investor Interest

AbCellera Biologics Inc. (NASDAQ: ABCL), a cutting-edge player in the biotechnology sector, is a company that has caught the attention of investors with its promising 59.82%..

Oric Pharmaceuticals (ORIC) Stock Analysis: A 35% Upside Potential Amidst Strong Buy Ratings

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to combating cancer resistance mechanisms. With..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unveiling a 205% Potential Upside Amidst Market Volatility

For investors seeking a potentially rewarding opportunity in the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents an intriguing case. This medical device company, headquartered in..

Phibro Animal Health Corporation (PAHC): Investor Outlook Highlights Robust Revenue Growth Amid Market Challenges

For investors eyeing the healthcare sector, particularly within the niche of animal health and nutrition, Phibro Animal Health Corporation (NASDAQ: PAHC) presents an intriguing case. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds